Aurora Biomed

03/20/2025

Powering Innovation in Forensic Science! 🔬✨

We had the pleasure of training QIAGEN HID and Forensics Application Validation Specialists on the VERSA Series, ensuring seamless automation for forensic workflows. The team is now fully ready to validate the NGS workflows on the Aurora VERSA platform, advancing Forensic Investigative Genetic Genealogy (FIGG). Are you?

03/06/2025

𝐂𝐡𝐫𝐨𝐧𝐢𝐜 𝐩𝐚𝐢𝐧 𝐢𝐦𝐩𝐚𝐜𝐭𝐬 𝐚𝐩𝐩𝐫𝐨𝐱𝐢𝐦𝐚𝐭𝐞𝐥𝐲 𝟏 𝐢𝐧 𝟓 𝐢𝐧𝐝𝐢𝐯𝐢𝐝𝐮𝐚𝐥𝐬, highlighting the urgent need opioid-free pain relief alternatives.

Scientific advancements in pain research have highlighted the identification of analgesic ion channel and transporter targets that could redefine pain medications. Aurora Biomed was the first to develop a non-radioactive, label-free technology for the study and high throughput screening of ion channel and transporter targets, and ever since it has granted a more thorough understanding of relevant pain targets, such as 𝐓𝐑𝐏, 𝐡𝐄𝐑𝐆, 𝐍𝐚𝐯𝟏.𝟕, 𝐀𝐒𝐈𝐂 𝐚𝐧𝐝 𝐍𝐊𝐂𝐂𝟏.

Ion Channel Readers (ICRs) are essential for advancing this research, aiding scientists in studying and developing safer medications for pain drug targets.

Learn more about this technology here or email us at info@aurorabiomed.com for more information:https://www.aurorabiomed.com/wp-content/uploads/2024/10/Aurora-Brochure-Ion-Channel-Readers.pdf

.7

Reference: International Association for the Study of Pain (IASP). (2023). High-impact chronic pain [Fact sheet]. Retrieved from https://www.iasp-pain.org/resources/fact-sheets/high-impact-chronic-pain/

02/20/2025

Global number of drug users has risen to nearly 300 million according to the United Nations Office on Drugs and Crime's 2024 World Drug Report.

As drug use continues to rise, the demand for reliable and efficient drug testing solutions increases in tandem. The process for sample preparation is 𝐒𝐨𝐥𝐢𝐝 𝐏𝐡𝐚𝐬𝐞 𝐄𝐱𝐭𝐫𝐚𝐜𝐭𝐢𝐨𝐧 (𝐒𝐏𝐄) as it enables the extraction, cleanup, and concentration of analytes before their identification and quantification.

Manual SPE workflows can be time consuming and prone to human errors. Aurora Biomed’s 𝐕𝐄𝐑𝐒𝐀 1100 𝐒𝐏𝐄 enhances efficiency by providing faster processing and minimizing contamination. It enables workflow automation through these four key steps:
1. 𝐖𝐞𝐭/𝐂𝐨𝐧𝐝𝐢𝐭𝐢𝐨𝐧𝐢𝐧𝐠: The sorbent is prepared to ensure consistent analyte retention and interaction.
2. 𝐋𝐨𝐚𝐝𝐢𝐧𝐠 𝐬𝐚𝐦𝐩𝐥𝐞𝐬: The analyte, along with some impurities, binds to the sorbent material.
3. 𝐖𝐚𝐬𝐡𝐢𝐧𝐠: A specialized solution removes weakly bound impurities while retaining the analyte.
4. 𝐄𝐥𝐮𝐭𝐞: The analyte is released from the sorbent and collected for analysis.

Learn more about the VERSA 1100 SPE here: https://www.aurorabiomed.com/product/automated-solid-phase-extraction-spe-system/

SPE can now be automated for drug testing including for urine samples. If you’re interested in automating your drug testing contact us at info@aurorabiomed.com. Our solutions can be customized around your needs.

Reference: United Nations. (2024). Drugs and crime. United Nations. Retrieved February 19, 2025, from https://www.un.org/en/global-issues/drugs

02/05/2025

Thank you to everyone who stopped by Aurora’s booth at SLAS (Society for Laboratory Automation and Screening) conference! Your support made this event possible, and your presence made this experience truly memorable.

This conference brought together professionals from diverse fields, all conglomerated to create something truly special. We enjoyed meeting new faces, as well as reconnecting with longtime friends. How are those legs holding up?

If you missed us, feel free to drop your contact information by sending us a quick email at info@aurorabiomed.com. Thank you once again, and we hope to see you very soon at the next conference!

01/29/2025

One more day until this year’s SLAS conference comes to an end!

This is your last chance to see the result of 25 𝐲𝐞𝐚𝐫𝐬 of dedication to manufacturing cutting-edge liquid handlers.

Come check out one of the most reliable systems on the market. Our team will be happy to walk you through the instrument configurations and diverse applications that can be accommodated.

Don't miss out!

01/29/2025

Have you stopped by booth # 108 yet at SLAS Conference?

We invite you to swing by Aurora’s booth before this grand event comes to an end.

Don’t miss your chance to see VERSA in action! Come learn how these versatile liquid handlers can streamline your workflow for simpler and consistent automation.

01/29/2025

What an amazing party yesterday at USS Midway 41 by Hamilton! The food and ambiance were spot on, but what really made it special was the incredible people. The whole atmosphere was so inviting, making it easy to relax, have fun, and just let loose.🎉💃🕺

Can’t wait for more nights like this in the days ahead!⏭️

01/28/2025

The SLAS Conference has officially begun! 🎉

Are you in the area? Stop by Aurora Biomed’s booth # 108 to meet our friendly team and discover how our VERSA line of lab automation solutions stand out!

This year we decided to showcase:
✅ Our 𝐛𝐞𝐬𝐭-𝐬𝐞𝐥𝐥𝐢𝐧𝐠automated liquid handler
✅ Our 𝐧𝐞𝐰𝐞𝐬𝐭 addition to the VERSA line, the VERSA™ 2000.

Meticulously designed to revolutionize 𝐠𝐞𝐧𝐨𝐦𝐢𝐜, 𝐦𝐞𝐭𝐚𝐛𝐨𝐥𝐨𝐦𝐢𝐜, and 𝐩𝐫𝐨𝐭𝐞𝐨𝐦𝐢𝐜 workflows, these systems help advance pivotal applications for 𝐩𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞, 𝐜𝐚𝐧𝐜𝐞𝐫 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬, and 𝐟𝐨𝐫𝐞𝐧𝐬𝐢𝐜𝐬.

Don’t believe us? Come by and see it for yourself.

01/23/2025

We warmly welcome you to visit us at Booth #108 during the 𝐒𝐋𝐀𝐒 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞, where Aurora Biomed's team will showcase the latest advancements in 𝐥𝐚𝐛 𝐚𝐮𝐭𝐨𝐦𝐚𝐭𝐢𝐨𝐧. Discover how our innovative liquid handling systems can seamlessly integrate into your workflows.

This time, we have the luxury of presenting you with our latest addition to lab automation solutions, the 𝐕𝐄𝐑𝐒𝐀™ 2000.

Don’t hesitate to email us at info@aurorabiomed.com for questions regarding lab automation. Let us show you how we can streamline your workflows with open-system platforms, with customization like no other

01/21/2025

SLAS Conference is right around the corner and we’re preparing for a very exciting week!

SLAS-2025 will be starting in just a few weeks in San Diego. From January 25-29, you will find us at booth #108, where we will highlight our line of automated liquid handlers, including our latest addition to lab automation: the VERSA™ 2000.

Don’t hesitate to stop by and say hi! 👋 Our highly dedicated team will be happy to welcome you to our booth and provide you with a rundown of our instrument capabilities.

Shoot us an email at info@aurorabiomed.com for more information 🧬

01/16/2025

The Contract Research Organization services market was estimated to be $76.6 billion in 2023 and is projected to reach $127.3 billion by 2028.

This growth is driven by the desire to leverage the specialized expertise, reduce costs, and accelerate drug development timelines that CROs can offer. In response to this trend, we provide nonclinical contract research services in drug discovery, safety and research, meeting the need for unique analytical testing approaches imperative to innovative solutions.

Click below to find more about our 𝗮𝘀𝘀𝗮𝘆 𝘀𝗲𝗿𝘃𝗶𝗰𝗲𝘀
https://www.aurorabiomed.com/preclinical-research-services/

12/17/2024

Congratulations to researchers from John Hopkins University and Johns Hopkins All Children's Hospital for their remarkable research on pulmonary hypertension (PAH) and its metabolic effects. The John Hopkins team utilized our to filter and prepare the tissue samples before conducting 𝗟𝗖-𝗠𝗦 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀, enabling precise sample handling through solid-phase extraction. Read about VERSA here: https://www.aurorabiomed.com/product/automated-liquid-handling/

Their method involved treating rodent models to mimic human PAH symptoms. Through this approach, they were able to extract tissue samples and analyze metabolic changes associated with the disease’s progression. Notably, they observed changes in tissue metabolite levels in addition to physical changes such as ventricular sizes.

Interested in learning more? Check out the white paper/publication below:
White paper:https://www.aurorabiomed.com/wp-content/uploads/2024/07/Aurora-Whitepaper-VERSA110-VersaMetabolicProfiing.pdf

Publication:https://www.aurorabiomed.com/wp-content/uploads/2024/07/2023-VERSA1100-SPE-LLE-Simpson-Spatial-and-temporal-resolution-of-metabolic-dysregulation-in-the-Sugen-hypoxia-model.pdf

Authors: Catherine E. Simon, Anjira S. Ambade,Robert Harlan MS,Aurelie ROUX, David Graham, Neal Klauer, Tijana Tuhy, Todd Kolb, Karthik Suresh, Paul Hassoun, Rachel Damico

Automated Liquid Handling System for Genomics including Next Generation Sequencing, NGS Library Preparation, Microarray spotting, and more.